Commodore Capital completely exited its 3.2 million share position in Viridian Therapeutics (worth $69 million) on February 17, 2026, reducing the holding from 3.4% of the fund's assets to zero. This comes despite Viridian's stock being up 75% over the past year and entering a catalyst-heavy 2026 with FDA approval decisions and Phase 3 data expected. The exit suggests the fund may be taking profits after the strong rally or reallocating capital to other clinical-stage biotech names.

BALVERSA (erdafitinib), a targeted therapy for FGFR-altered urothelial carcinoma, has strong market potential as precision oncology gains emphasis. Its uptake is expected to increase, especially if expanded to earlier treatment lines or additional FGFR-driven tumors.

The advanced urothelial carcinoma market is witnessing significant growth, driven by an aging population and the rising prevalence of metastatic cases. Advances in immunotherapy and targeted treatments are transforming the treatment landscape, with over 20 key companies developing new therapies.

Tyra Biosciences, a leading biotechnology company, has reached a new 52-week high of $21.67, reflecting its robust performance and investor confidence. The company has made progress in the development of its therapeutic candidate TYRA-300 for hypochondroplasia, with positive preclinical data presented at a research conference.

Tyra Biosciences (TYRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The consensus price target hints at a 27.3% upside potential for Tyra Biosciences (TYRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.8% on Friday. The Dow traded up 0.49% to 38,705.29 while the NASDAQ rose 1.81% to 15,639.81. The S&P 500 also rose, gaining, 1.20% to 4,965.03. Check This Out: Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday   Leading and Lagging Sectors   Communication services shares rose by 4.1% on Friday. In trading on Friday, real estate shares fell by 1.9%.   Top Headline   Amazon.com, Inc. (NASDAQ: AMZN) posted stronger-than-expected results for its fourth quarter. The company said it sees first-quarter revenue to be between $138 billion and $143.5 billion versus estimates of $142.13 billion. Operating income is expected to be between $8 billion and $12 billion in the first quarter.   Equities Trading UP   Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares shot up 101% to $4.84. Intelligent Bio Solutions said it sees preliminary second-quarter revenue of $0.76 million. Shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) got a boost, surging 24% to $16.19. Tyra ...

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results. Skechers said fourth-quarter revenue increased 4.4% year-over-year to $1.96 billion, which missed the consensus estimate of $2.03 billion, according to Benzinga Pro. The company reported quarterly earnings of 56 cents per share, which beat analyst estimates of 54 cents per share. Skechers shares fell 6.9% to $59.21 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares jumped 77.6% to $4.28. Intelligent Bio Solutions said it sees preliminary second-quarter revenue of $0.76 million. Minim, Inc. (NASDAQ: MINM) shares rose 34.4% to $6.76 after gaining more than 22% on Thursday. Remark Holdings, Inc. (NASDAQ: MARK) shares climbed 33% to $0.6802. Kopin Corporation (NASDAQ: KOPN) jumped 30% to $2.4050. BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 26.3% to $2.73. Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) gained 23% to $14.65. Tyra Biosciences, Inc. (NASDAQ: TYRA) gained 21.8% to $15.84. Tyra Biosciences announced a $200 million private placement financing. Meta Platforms, Inc. (NASDAQ: META) rose 18.9% to $469.34 as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share. CCSC Technology International Holdings Limited (NASDAQ: CCTG) gained 18.2% to $4.6099 after dipping around 82% on Thursday. Roma Green Finance Limited (NASDAQ: ROMA) gained 15.8% to $0.8697 after gaining around 5% on Thursday. Deckers Outdoor Corporation (NYSE: DECK) surged 14% to $879.03 after reporting better-than-expected third-quarter financial results. Trugolf, Inc. (NASDAQ: TRUG) shares jumped 14% to ...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 0.19% to 38,593.49 while the NASDAQ rose 1.55% to 15,600.39. The S&P 500 also rose, gaining, 0.97% to 4,953.70. Check This Out: Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday   Leading and Lagging Sectors   Communication services shares rose by 4.1% on Friday. In trading on Friday, real estate shares fell by 2.3%.   Top Headline   Apple Inc. (NASDAQ: AAPL) reported better-than-expected earnings and revenue for its first quarter. The iPhone maker reported first-quarter earnings per share of $2.18 and revenue of $119.6 billion, thanks to record Services revenue and iPhone revenue. However, the company reported a revenue decline in China.   Equities Trading UP   Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares shot up 80% to $4.34. Intelligent Bio Solutions said it sees preliminary second-quarter revenue of $0.76 million. Shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) got a boost, surging 23% to $15.99. Tyra Biosciences announced a $200 million ...

U.S. stocks traded mixed, with the Dow Jones falling over 100 points on Friday. Shares of The Clorox Company (NYSE: CLX) shares gained during Friday’s session after the company reported better-than-expected second-quarter financial results and raised FY24 adjusted EPS guidance above estimates. Clorox shares rose 4.6% to $154.77 on Friday. Here are some other big stocks recording gains in today’s session. Tyra Biosciences, Inc. (NASDAQ: TYRA) shares rose 21.8% to $15.84. Tyra Biosciences, announced a $200 million private placement financing. Meta Platforms, Inc. (NASDAQ: META) climbed 18.9% to $469.34 as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share. Deckers Outdoor Corporation (NYSE: DECK) gained 14% to $879.03 after reporting better-than-expected third-quarter financial results. Gaotu Techedu Inc. (NYSE: ...

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today’s session. Yatsen Holding Limited (NYSE: YSG) shares tumbled 24.2% to $0.6559. Yatsen Holding is expected to release its unaudited financial results for the third quarter on Nov. 21, 2023. Syntec Optics Holdings, Inc. (NASDAQ: OPTX) fell 11.3% to $7.95. OptimizeRx recently issued strong FY23 guidance. reAlpha Tech Corp. (NASDAQ:

Within the last quarter, Tyra Biosciences (NASDAQ:TYRA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 1 1 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Tyra Biosciences has an average price target of $22.75 with a high of $27.00 and a low of $17.00. Below is a summary of how these 4 analysts rated Tyra Biosciences over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number ...Full story available on Benzinga.com